法国生物物理学家帕斯卡尔·梅耶——颠覆常规，挑战“不可能”

Core Insights - Pascal Meyer, a pioneer in next-generation sequencing (NGS), revolutionized DNA sequencing by developing a method to cut DNA molecules into small segments and read their sequences on solid surfaces, which was initially met with skepticism from peers [2][4] - Meyer has received prestigious awards, including the 2022 Life Sciences Breakthrough Prize and the 2024 Gairdner International Award, for his contributions to drug development and precision medicine [2] - His company, Alphanosos, is now focusing on the intersection of natural plants and artificial intelligence to address global health challenges [6][9] Company and Industry Developments - Alphanosos utilizes AI models to rapidly identify optimal and safe plant compound combinations, significantly reducing the time required for research and development from years to months [6][8] - The company aims to create personalized treatment plans, aligning with the ancient wisdom of Chinese dietary practices that emphasize individual needs [7] - Meyer emphasizes the importance of collaboration and knowledge sharing between China and Europe in health technology and natural drug research, highlighting the complementary advantages of both regions [8][9] Research and Innovation - The innovative approach of simplifying complex processes has been a guiding principle for Meyer, leading to breakthroughs in DNA sequencing and now in AI-driven health solutions [5][6] - Meyer’s leadership style encourages open dialogue and innovation within his team, fostering an environment where questioning and exploring new ideas is valued [8] - The ongoing research at Alphanosos targets pressing global health issues, including rare genetic disorders and antibiotic resistance, aiming to develop rapid response platforms for public health challenges [8][9]